A preliminary attempt to personalize risperidone dosing using drug-drug interactions and genetics: part II.
de Leon
Jose
J
University of Kentucky Mental Health Research Center at Eastern State Hospital, 627 West 4th St., Lexington, KY 40508, USA. jdeleon@uky.edu
Sandson
Neil B
NB
Cozza
Kelly L
KL
D000544:Alzheimer Disease / Q000453:epidemiology / Q000235:genetics; D002648:Child; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics; D003577:Cytochrome P-450 Enzyme System / Q000235:genetics*; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D004347:Drug Interactions; D006801:Humans; D008607:Intellectual Disability / Q000453:epidemiology / Q000235:genetics; D018802:Patient-Centered Care; D018967:Risperidone / Q000008:administration & dosage* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy* / Q000453:epidemiology / Q000235:genetics*
D003577:Cytochrome P-450 Enzyme System; D019389:Cytochrome P-450 CYP2D6; D018967:Risperidone